Search
for
Sort by
Research 331–360 of 1000+
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study
- Real-World Ritlecitinib Treatment of Severe Alopecia Areata (AA) in the US: Patient Characteristics and Physician Satisfaction
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Baricitinib as a treatment for myasthenia gravis: A case report
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Deucravacitinib in dermatology: current indication and existing off-label data
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- JAK inhibitors and alopecia areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis